Product
cAD3-Sudan Ebolavirus Vaccine
1 clinical trial
1 indication
Indication
Ebola Sudan virus diseaseClinical trial
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy AdultsStatus: Not yet recruiting, Estimated PCD: 2024-06-01